Serum carnosinase activities in central nervous system disorders

Area of Science:

• Biochemistry
• Neurology
• Enzymology

Background:

• Serum carnosinase plays a role in neurological function.
• Assessing enzyme activity can provide insights into disease states.
• Neurological disorders encompass a range of conditions affecting the brain and nervous system.

Purpose of the Study:

• To investigate serum carnosinase activity in patients with various neurological disorders.
• To compare enzyme levels in patient groups with a healthy control group.
• To explore potential correlations between carnosinase activity and central nervous system conditions.

Main Methods:

• Assay of serum carnosinase activity.
• Comparison of enzyme levels across five patient groups and a control group.
• Analysis of cerebrospinal fluid (CSF) carnosinase activity.

Main Results:

• Serum carnosinase activity was similar in patients with idiopathic epilepsy and motor neurone disease compared to controls.
• Significantly reduced serum carnosinase activity was observed in patients with Parkinson's disease, multiple sclerosis, and post-cerebrovascular accident.
• Low carnosinase activity was also detected in CSF samples.

Conclusions:

• Reduced serum carnosinase activity is associated with specific neurological disorders, including Parkinson's disease, multiple sclerosis, and cerebrovascular accidents.
• The exact cause of decreased carnosinase activity in these CNS disorders remains unclear.
• Potential contributing factors include anoxic damage or blood-brain barrier disruption.